Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial Group. [electronic resource]
Producer: 19970409Description: 803-13 p. digitalISSN:- 0168-8278
- Adult
- Antiviral Agents -- administration & dosage
- Biopsy
- Chronic Disease
- DNA, Viral -- analysis
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Synergism
- Female
- Follow-Up Studies
- Glucocorticoids -- administration & dosage
- Hepatitis B -- blood
- Hepatitis B Antibodies -- analysis
- Hepatitis B e Antigens -- immunology
- Hepatitis B virus -- genetics
- Humans
- Interferon-alpha -- administration & dosage
- Male
- Prednisolone -- administration & dosage
- Transaminases -- blood
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.